4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-21-078230
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: Jun 08, 2021
Reporting period: Jun 06, 2021
Description: Insider transaction

Documents

0001104659-21-078230-index.htm

Complete submission

0001104659-21-078230.txt

directory listing

Filed by

Nabriva Therapeutics plc